Artificial Intelligence Product Rollout for Fortune 50 Pharma Company
Axiom attorneys helped to:
*Cost savings estimates are based on actual Axiom rates compared to equivalent law firm rate averages as listed in Wolters Kluwer’s Real Rate report.
Challenge
A global pharma powerhouse recently established a new digital technology arm. However, the internal legal team lacked the expertise required to navigate the complex intersection of AI, tech and pharma law. With myriad acquisitions, partnerships, and existing/future regulations, the new digital org needed a partner to help address data privacy, AI, IP, and regulatory compliance concerns.
Approach
Axiom deployed a tailored team of lawyers with extensive experience supporting technology roll-outs, including new AI products. The Axiom team drafted and negotiated vendor agreements, statements of work, and affiliate agreements with an eye towards data processing and privacy implications. They also issue spotted to ensure compliance with healthcare regulations like HIPAA and anti-kickback rules. Additional Axiom tech IP lawyers supported patent drafting for digital assets which the new org was developing internally and acquiring from external partners and sources.
Impact
- At its peak, a team of 7 lawyers and 1 project manager enabled client’s legal team to rapidly scale and meet the needs of the new digital org without taking away legal support from their other business verticals
- By providing tech and generative AI knowledge that the client lacked in-house, Axiom enabled client to implement new AI tools for their customers while adhering to regulatory compliance rules
- Slashed administrative burden of coordinating review across legal functions (M&A/Licensing, Procurement, IP, data privacy) to streamline client’s digital asset transactions
Get in touch
We'll reach out to you and schedule a consultation to discuss potential legal talent solutions based on your company priorities, legal team, and legal work.
* Required